Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


NMDA Dysregulation in Individuals With a Family Vulnerability to Alcoholism


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00588952

Organisation Name: Yale University

Overal Status: Completed

Start Date: March 2001

Last Update: March 3, 2017

Lead Sponsor: Yale University

Brief Summary: The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.

Conditions:
  • Alcoholism


Total execution time in seconds: 0.18019008636475